Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15892162 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL15850631 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL15060563 | 0.88 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL12434623 | 0.88 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL15850632 | 0.85 | TAS1R3 (0.46) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL19981039 | 0.85 | TAS1R3 (0.46) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL15892164 | 0.85 | TAS1R3 (0.46) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL20215731 | 0.85 | TAS1R3 (0.46) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 | |
| SCHEMBL17853312 | 0.82 | — | — | |
| SCHEMBL15892169 | 0.81 | TAS1R3 (0.44) | ALDH1A1MEN1KMT2AKDM4ETAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10377788-B2 | Method for producing glycoside compounds | BONAC CORPORATION (JP) | 2019-08-13 | — | — | US | disclosed |
| US-20180079768-A1 | METHOD FOR PRODUCING GLYCOSIDE COMPOUNDS | BONAC CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10377788-B2 | Method for producing glycoside compounds | TST, DIMT1, DERA | ALDH1A1 808/4885MEN1 1456/4885KMT2A 1183/4885 |
| US-20180079768-A1 | METHOD FOR PRODUCING GLYCOSIDE COMPOUNDS | TST, DIMT1, DERA | ALDH1A1 808/4885MEN1 1456/4885KMT2A 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.